Physiologic mechanisms opposing the hemodynamic effects of prazosin View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1981-01

AUTHORS

Joseph L Izzo, David Horwitz, Harry R Keiser

ABSTRACT

Prazosin was give for 10 to 14 days to eight hypertensive patients on a fixed intake of dietary salt. Except as limited by side effects, the dose was increased from 2 mg/day to a maximum dose of 24 mg/day. During treatment, when subjects were studied in supine and upright positions, mean arterial pressure (MAP) fell 6% and 12% (p less than 0.025 and p less than 0.005), heart rate rose 3% and 9% (p less than 0.05 and p less than 0.005), and plasma norepinephrine increased 95% and 107% (p less than 0.01 and p less than 0.001) over control. Daily excretion of the norepinephrine metabolites methoxyhydroxyphenyl glycol (MHPG) and vanillylmandelic acid (VMA) increased 42% and 17% (p less than 0.05 for each) during treatment. There were no changes in average body weight or plasma renin for the group, but patients whose body weight increased tended to show less reduction in blood pressure (correlation coefficient, r = 0.72, p less than 0.05) and smaller increases in heart rate (r = -.073, p less than 0.05) during treatment with prazosin. These data suggest that expansion of extracellular fluid and activation of the sympathetic nervous system oppose the hemodynamic effects of prazosin. More... »

PAGES

7-11

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/clpt.1981.2

DOI

http://dx.doi.org/10.1038/clpt.1981.2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038348725

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7460477


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Extracellular Space", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Norepinephrine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Posture", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prazosin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quinazolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sympathetic Nervous System", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Rochester", 
          "id": "https://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Department of Medicine University of Rochester Rochester", 
            "Hypertension\u2010Endocrine Branch, National Heart Lung", 
            "Blood Institute, National Institutes of Health Bethesda"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Izzo", 
        "givenName": "Joseph L", 
        "id": "sg:person.01174457147.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174457147.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Rochester", 
          "id": "https://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Department of Medicine University of Rochester Rochester", 
            "Hypertension\u2010Endocrine Branch, National Heart Lung", 
            "Blood Institute, National Institutes of Health Bethesda"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Horwitz", 
        "givenName": "David", 
        "id": "sg:person.01166013535.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166013535.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Rochester", 
          "id": "https://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Department of Medicine University of Rochester Rochester", 
            "Hypertension\u2010Endocrine Branch, National Heart Lung", 
            "Blood Institute, National Institutes of Health Bethesda"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Keiser", 
        "givenName": "Harry R", 
        "id": "sg:person.0663532737.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663532737.84"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0009-8981(62)90022-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001808232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0009-8981(62)90022-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001808232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.55.3.533", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006609737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(79)90185-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023925806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(77)91822-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029304003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(79)90409-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035662457"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(78)90735-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043586068"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1552-4604.1979.tb02508.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050182884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jcem-29-10-1349", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064306791"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1981-01", 
    "datePublishedReg": "1981-01-01", 
    "description": "Prazosin was give for 10 to 14 days to eight hypertensive patients on a fixed intake of dietary salt. Except as limited by side effects, the dose was increased from 2 mg/day to a maximum dose of 24 mg/day. During treatment, when subjects were studied in supine and upright positions, mean arterial pressure (MAP) fell 6% and 12% (p less than 0.025 and p less than 0.005), heart rate rose 3% and 9% (p less than 0.05 and p less than 0.005), and plasma norepinephrine increased 95% and 107% (p less than 0.01 and p less than 0.001) over control. Daily excretion of the norepinephrine metabolites methoxyhydroxyphenyl glycol (MHPG) and vanillylmandelic acid (VMA) increased 42% and 17% (p less than 0.05 for each) during treatment. There were no changes in average body weight or plasma renin for the group, but patients whose body weight increased tended to show less reduction in blood pressure (correlation coefficient, r = 0.72, p less than 0.05) and smaller increases in heart rate (r = -.073, p less than 0.05) during treatment with prazosin. These data suggest that expansion of extracellular fluid and activation of the sympathetic nervous system oppose the hemodynamic effects of prazosin.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/clpt.1981.2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2423965", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2670579", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "name": "Physiologic mechanisms opposing the hemodynamic effects of prazosin", 
    "pagination": "7-11", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b6adcf6e9921ed461bbef2adee6a7455104c43bb0cede5d5f3847e793f45a0f8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7460477"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/clpt.1981.2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038348725"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/clpt.1981.2", 
      "https://app.dimensions.ai/details/publication/pub.1038348725"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000066.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1038/clpt.1981.2/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.2'


 

This table displays all metadata directly associated to this object as RDF triples.

173 TRIPLES      21 PREDICATES      52 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/clpt.1981.2 schema:about N233177bc6fb74996aead610d9265ba0e
2 N23e6e618473349908d916c92daac191c
3 N257afe98b4144871b02165166787aaed
4 N3426e1a3d810483f8695198b5b273d8a
5 N3e7bdcdea420458998aed1cc54681a3e
6 N555f86ee757a4220b59d9451731af84e
7 N6ed67777b7d3430e8083f9a5512fac56
8 Na3775224e42c451b808925b41c40d734
9 Ncbf1bea5e3d24b858f8cc9aeaac3e667
10 Nd5fb7e4687be4e9fbeb6681c9cb0cf56
11 Ndd65b9594872449db8aa9c9c00103c43
12 Nf107d069798249daa34a3f4f8858d923
13 Nf38beabccdc74df3b06cd9c30bb21cb5
14 Nf7198793bd614a709e60b74a5e0e609f
15 Nfdbfd8141bfb4c9a81b877421ea6f129
16 anzsrc-for:11
17 anzsrc-for:1116
18 schema:author Ncb10bafbe7d641e28a819744201996b3
19 schema:citation https://doi.org/10.1002/j.1552-4604.1979.tb02508.x
20 https://doi.org/10.1016/0002-9149(78)90735-x
21 https://doi.org/10.1016/0002-9149(79)90185-1
22 https://doi.org/10.1016/0002-9149(79)90409-0
23 https://doi.org/10.1016/0009-8981(62)90022-0
24 https://doi.org/10.1016/s0140-6736(77)91822-0
25 https://doi.org/10.1161/01.cir.55.3.533
26 https://doi.org/10.1210/jcem-29-10-1349
27 schema:datePublished 1981-01
28 schema:datePublishedReg 1981-01-01
29 schema:description Prazosin was give for 10 to 14 days to eight hypertensive patients on a fixed intake of dietary salt. Except as limited by side effects, the dose was increased from 2 mg/day to a maximum dose of 24 mg/day. During treatment, when subjects were studied in supine and upright positions, mean arterial pressure (MAP) fell 6% and 12% (p less than 0.025 and p less than 0.005), heart rate rose 3% and 9% (p less than 0.05 and p less than 0.005), and plasma norepinephrine increased 95% and 107% (p less than 0.01 and p less than 0.001) over control. Daily excretion of the norepinephrine metabolites methoxyhydroxyphenyl glycol (MHPG) and vanillylmandelic acid (VMA) increased 42% and 17% (p less than 0.05 for each) during treatment. There were no changes in average body weight or plasma renin for the group, but patients whose body weight increased tended to show less reduction in blood pressure (correlation coefficient, r = 0.72, p less than 0.05) and smaller increases in heart rate (r = -.073, p less than 0.05) during treatment with prazosin. These data suggest that expansion of extracellular fluid and activation of the sympathetic nervous system oppose the hemodynamic effects of prazosin.
30 schema:genre research_article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf N8079587b52af4224ae8ae580024073bc
34 Ndab608f346e94892be7446a3dcbee610
35 sg:journal.1017409
36 schema:name Physiologic mechanisms opposing the hemodynamic effects of prazosin
37 schema:pagination 7-11
38 schema:productId N6e4dae7543be4aec85c8a510e8930ee7
39 N7c53fad09d5f43ba8305361232519276
40 Nb78d2f6600dd499797f5b99178dec4e5
41 Nd71e888b0c4f498c9184d932e908a0e7
42 Ne1795bae745f4b1fbcc357bf7b09e603
43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038348725
44 https://doi.org/10.1038/clpt.1981.2
45 schema:sdDatePublished 2019-04-10T21:59
46 schema:sdLicense https://scigraph.springernature.com/explorer/license/
47 schema:sdPublisher Nbd7f1852161849ea91dedb33d045c297
48 schema:url http://onlinelibrary.wiley.com/doi/10.1038/clpt.1981.2/abstract
49 sgo:license sg:explorer/license/
50 sgo:sdDataset articles
51 rdf:type schema:ScholarlyArticle
52 N233177bc6fb74996aead610d9265ba0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
53 schema:name Heart Rate
54 rdf:type schema:DefinedTerm
55 N23e6e618473349908d916c92daac191c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Extracellular Space
57 rdf:type schema:DefinedTerm
58 N257afe98b4144871b02165166787aaed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Adult
60 rdf:type schema:DefinedTerm
61 N3426e1a3d810483f8695198b5b273d8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Male
63 rdf:type schema:DefinedTerm
64 N3e7bdcdea420458998aed1cc54681a3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Female
66 rdf:type schema:DefinedTerm
67 N3f535aba960548179eea47fac91eaf71 rdf:first sg:person.01166013535.73
68 rdf:rest N938050956e374aad90758d7569a19c9d
69 N555f86ee757a4220b59d9451731af84e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Sympathetic Nervous System
71 rdf:type schema:DefinedTerm
72 N6e4dae7543be4aec85c8a510e8930ee7 schema:name pubmed_id
73 schema:value 7460477
74 rdf:type schema:PropertyValue
75 N6ed67777b7d3430e8083f9a5512fac56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Hypertension
77 rdf:type schema:DefinedTerm
78 N7c53fad09d5f43ba8305361232519276 schema:name nlm_unique_id
79 schema:value 0372741
80 rdf:type schema:PropertyValue
81 N8079587b52af4224ae8ae580024073bc schema:issueNumber 1
82 rdf:type schema:PublicationIssue
83 N938050956e374aad90758d7569a19c9d rdf:first sg:person.0663532737.84
84 rdf:rest rdf:nil
85 Na3775224e42c451b808925b41c40d734 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Quinazolines
87 rdf:type schema:DefinedTerm
88 Nb78d2f6600dd499797f5b99178dec4e5 schema:name doi
89 schema:value 10.1038/clpt.1981.2
90 rdf:type schema:PropertyValue
91 Nbd7f1852161849ea91dedb33d045c297 schema:name Springer Nature - SN SciGraph project
92 rdf:type schema:Organization
93 Ncb10bafbe7d641e28a819744201996b3 rdf:first sg:person.01174457147.49
94 rdf:rest N3f535aba960548179eea47fac91eaf71
95 Ncbf1bea5e3d24b858f8cc9aeaac3e667 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Norepinephrine
97 rdf:type schema:DefinedTerm
98 Nd5fb7e4687be4e9fbeb6681c9cb0cf56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Prazosin
100 rdf:type schema:DefinedTerm
101 Nd71e888b0c4f498c9184d932e908a0e7 schema:name dimensions_id
102 schema:value pub.1038348725
103 rdf:type schema:PropertyValue
104 Ndab608f346e94892be7446a3dcbee610 schema:volumeNumber 29
105 rdf:type schema:PublicationVolume
106 Ndd65b9594872449db8aa9c9c00103c43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 Ne1795bae745f4b1fbcc357bf7b09e603 schema:name readcube_id
110 schema:value b6adcf6e9921ed461bbef2adee6a7455104c43bb0cede5d5f3847e793f45a0f8
111 rdf:type schema:PropertyValue
112 Nf107d069798249daa34a3f4f8858d923 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Blood Pressure
114 rdf:type schema:DefinedTerm
115 Nf38beabccdc74df3b06cd9c30bb21cb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Posture
117 rdf:type schema:DefinedTerm
118 Nf7198793bd614a709e60b74a5e0e609f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Middle Aged
120 rdf:type schema:DefinedTerm
121 Nfdbfd8141bfb4c9a81b877421ea6f129 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Hemodynamics
123 rdf:type schema:DefinedTerm
124 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
125 schema:name Medical and Health Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
128 schema:name Medical Physiology
129 rdf:type schema:DefinedTerm
130 sg:grant.2423965 http://pending.schema.org/fundedItem sg:pub.10.1038/clpt.1981.2
131 rdf:type schema:MonetaryGrant
132 sg:grant.2670579 http://pending.schema.org/fundedItem sg:pub.10.1038/clpt.1981.2
133 rdf:type schema:MonetaryGrant
134 sg:journal.1017409 schema:issn 0009-9236
135 1532-6535
136 schema:name Clinical Pharmacology & Therapeutics
137 rdf:type schema:Periodical
138 sg:person.01166013535.73 schema:affiliation https://www.grid.ac/institutes/grid.16416.34
139 schema:familyName Horwitz
140 schema:givenName David
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166013535.73
142 rdf:type schema:Person
143 sg:person.01174457147.49 schema:affiliation https://www.grid.ac/institutes/grid.16416.34
144 schema:familyName Izzo
145 schema:givenName Joseph L
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174457147.49
147 rdf:type schema:Person
148 sg:person.0663532737.84 schema:affiliation https://www.grid.ac/institutes/grid.16416.34
149 schema:familyName Keiser
150 schema:givenName Harry R
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663532737.84
152 rdf:type schema:Person
153 https://doi.org/10.1002/j.1552-4604.1979.tb02508.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050182884
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/0002-9149(78)90735-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043586068
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/0002-9149(79)90185-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023925806
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/0002-9149(79)90409-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035662457
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1016/0009-8981(62)90022-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001808232
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1016/s0140-6736(77)91822-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029304003
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1161/01.cir.55.3.533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006609737
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1210/jcem-29-10-1349 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064306791
168 rdf:type schema:CreativeWork
169 https://www.grid.ac/institutes/grid.16416.34 schema:alternateName University of Rochester
170 schema:name Blood Institute, National Institutes of Health Bethesda
171 Department of Medicine University of Rochester Rochester
172 Hypertension‐Endocrine Branch, National Heart Lung
173 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...